SYNOPSIS Two groups of women with non-specific genital infection were treated for two weeks with tetracycline 250 mg six-hourly and minocycline 100 mg twice daily respectively. Cultures for yeasts were performed before treatment and at the end of the first and second weeks. Before treatment yeasts, mostly Candida albicans, were recovered from 13 % of the women. After one and two weeks' treatment yeasts were isolated from 22 and 29 % of women treated with tetracycline, and from 19 and 29% of women treated with minocycline. It is concluded that despite inhibition of the growth of yeasts shown by minocycline in vitro, there is no evidence of any significant difference between the actions of tetracycline and minocycline on the vaginal yeast flora.
Minocycline is a recently introduced semi-synthetic tetracycline. Unlike other tetracyclines it has been shown to inhibit the growth of Candida albicans in vitro in relatively low concentrations; a disc containing 30 ,jg produces a zone of inhibition about 13 mm in diameter, though this inhibition is much affected by the composition of the medium (Waterworth, 1974) .
It has been known for many years that therapy with tetracyclines may be accompanied by an overgrowth of yeasts, particularly C. albicans, in the intestinal and lower urogenital tracts (Winner and Hurley, 1964) . This overgrowth is often asymptomatic but may at times be accompanied by clinical signs such as stomatitis, pruritus ani or vulvovaginitis. The cause is uncertain; the suppression of inhibitory bacteria by tetracyclines may allow the overgrowth of yeasts, or alternatively low concentrations of tetracyclines may directly potentiate yeast replication.
In view of the inhibitory effect shown by minocycline against Candida spp. in vitro it might be hoped that less yeast overgrowth would occur in patients treated with this drug than with other tetracyclines. We have investigated this possibility by comparing the effect of oral tetracycline and minocycline on the vaginal yeast flora.
Subjects and Methods
The patients studied were women attending the Received for publication 27 November 1974. Department of Genito-Urinary Medicine, University College Hospital with the diagnosis of non-specific genital infection (NSGI). They usually came because they were sexual contacts of men with nonspecific urethritis. After excluding infection with Neisseria gonorrhoeae and Trichomonas vaginalis it is our practice to treat these women with a course of a tetracycline.
CLINICAL EXAMINATION
Patients were examined in the lithotomy position. The external genitalia were inspected and the vagina and cervix examined after the insertion of a Cusco speculum. Vulvovaginitis was defined as vulval or vaginal erythema with or without vulval scaling, oedema or excoriation and with or without the presence of vaginal plaques.
Specimens were collected from patients on first attendance as follows:
1 Cervical and urethral material was spread on glass slides, and culture plates for N. gonorrhoeae were inoculated. (Oriel et al, 1972; Hurley, Leask, Faktor, and de Fonseka, 1973) , we found T. glabrata to be the second commonest yeast isolated after C. albicans.
Both tetracycline and minocycline appear to have a definite effect on yeast isolation, the isolation rate being approximately doubled after a two-week oral course. There was no significant difference between minocycline and tetracycline in this respect, and our hopes that minocycline might be less liable to cause yeast overgrowth were not fulfilled. Perhaps the effect of minocycline on commensal bacteria leading to an alteration in vaginal yeast flora is of more importance than any direct inhibitory action of the antibiotic against yeasts. (Smits, Prior, and Arblaster, 1966) . 
